1. Home
  2. TECH vs DLB Comparison

TECH vs DLB Comparison

Compare TECH & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$59.83

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$63.49

Market Cap

6.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
DLB
Founded
1976
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
6.4B
IPO Year
1989
2005

Fundamental Metrics

Financial Performance
Metric
TECH
DLB
Price
$59.83
$63.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
5
Target Price
$71.23
$93.60
AVG Volume (30 Days)
1.6M
591.2K
Earning Date
02-04-2026
01-28-2026
Dividend Yield
0.54%
2.24%
EPS Growth
N/A
N/A
EPS
0.49
2.62
Revenue
$1,216,732,000.00
$1,349,130,000.00
Revenue This Year
$2.33
$5.03
Revenue Next Year
$7.05
$4.02
P/E Ratio
$120.82
$24.51
Revenue Growth
3.85
5.92
52 Week Low
$46.01
$64.02
52 Week High
$79.28
$89.66

Technical Indicators

Market Signals
Indicator
TECH
DLB
Relative Strength Index (RSI) 50.87 29.74
Support Level $58.54 $65.96
Resistance Level $59.64 $66.34
Average True Range (ATR) 1.46 1.00
MACD 0.11 -0.32
Stochastic Oscillator 80.40 0.41

Price Performance

Historical Comparison
TECH
DLB

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Share on Social Networks: